Find Research Projects

Search results

• Anti-SARS-CoV-2 activities of compounds (Oregon Health & Science University)

  Huang, C.

  4/23/20 → 10/22/20

  Project: Other project

• Anti-SARS-CoV-2 activities of compounds (Oregon Health & Science University)

  Huang, C.

  Oregon Health Sciences University

  4/23/20 → 10/22/20

  Project: Other project

• Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

  Saade, G.

  9/14/19 → 7/31/22

  Project: Other project

• Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

  Saade, G.

  9/14/19 → 10/10/21

  Project: Other project

• Antithrombin III (AT) Activity in Women with Severe Preeclampsia (PE) or Superimposed PE prior to 31 weeks

  Saade, G.

  9/14/19 → 7/31/22

  Project: Other project

• Antiviral Activity Testing of NeutroPhase Against Ebola Virus

  Freiberg, A.

  5/15/15 → 7/31/15

  Project: Other project

• Antiviral Activity Testing of NeutroPhase Against Ebola Virus

  Freiberg, A.

  5/15/15 → 7/31/15

  Project: Other project

• Antiviral Drug Testing and Resistance Selection

  Shi, P.

  2/1/21 → 10/31/21

  Project: Other project

• Antiviral Drug Testing and Resistance Selection

  Shi, P.

  Atea Pharmaceuticals Incorporated

  2/1/21 → 10/31/21

  Project: Other project

• Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model

  Geisbert, T.

  6/1/21 → 5/31/23

  Project: Other project

• Antiviral Efficacy Assessment of Arbutus Compounds in a SARS CoV-2 Hamster Infection Model

  Geisbert, T.

  6/1/21 → 5/31/23

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  VenatoRx Pharmaceuticals, Inc.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Aguilar, P.

  12/1/17 → 7/31/19

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  3/1/15 → 2/15/16

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Aguilar, P.

  12/1/17 → 7/31/19

  Project: Other project

• Antiviral profiling of alphavirus inhibitors

  Weaver, S.

  3/1/15 → 2/15/16

  Project: Other project

• Antivirals against Lassa (Sponsored Programs Contract)

  Paessler, S.

  11/1/18 → 10/31/19

  Project: Other project

• Antivirals against Lassa (Sponsored Programs Contract)

  Paessler, S.

  11/1/18 → 10/31/19

  Project: Other project

• Antiviral Testing of Inhibitors of SARS-CoV-2

  Shi, P.

  Aligos Therapeutics Inc

  12/1/20 → 6/30/21

  Project: Other project

• Antiviral therapies against re-emerging pathogens

  Paessler, S.

  2/1/15 → 12/31/16

  Project: Other project

• Antiviral therapies against re-emerging pathogens

  Paessler, S.

  2/1/15 → 12/31/16

  Project: Other project

• A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections¿

  Aigbivbalu, L.

  11/13/13 → 11/12/15

  Project: Other project

• A Phase 1,Open Label, Single Dose Study to Investigate the Pharmacokinetics, Safety and Tolerability of Dalbavancin in Hospitalized Children Aged 3 Months to 11 Years Receiving Standard Intravenous Anti-Infective Treatment for Bacterial Infections¿

  Aigbivbalu, L.

  11/13/13 → 11/12/15

  Project: Other project

• A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

  Rupp, R.

  Astellas Pharma Global Development Inc

  6/19/20 → 6/18/23

  Project: Other project

• A Phase 1, Randomized, Single Dose, Blinded, Dose-Escalation Study to Assess Safety, Tolerability and Immunogenicity of ASP3772, a Pneumococcal Vaccine, in Toddlers 12 to 15 Months of Age in Comparison to an Active Comparator

  Rupp, R.

  6/19/20 → 6/18/23

  Project: Other project

• A PHASE 1, SINGLE-ASCENDING DOSE, MULTIPLE-ASCENDING DOSE, AND MULTI DOSE SAFETY, TOLERABILITY, PHARAMCOKINETICS, AND PHARACODYNAMICS STUDY OF SUBCUTANEOUSLY ADMINISTERED ALN-AS1 IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP)

  Anderson, K.

  1/22/16 → 1/21/19

  Project: Other project

• A PHASE 1, SINGLE-ASCENDING DOSE, MULTIPLE-ASCENDING DOSE, AND MULTI DOSE SAFETY, TOLERABILITY, PHARAMCOKINETICS, AND PHARACODYNAMICS STUDY OF SUBCUTANEOUSLY ADMINISTERED ALN-AS1 IN PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA (AIP)

  Anderson, K.

  1/22/16 → 1/21/19

  Project: Other project

• A Phase 1/2, First-Time-in Human (FTiH), randomized, observer-blind, placebo-controlled, dose escalation study to assess safety, reactogenicity and immunogenicity of a candidate cytomegalovirus (CMV) vaccine comprising recombinant protein and adjuvant wh

  Rupp, R.

  11/12/21 → 11/11/26

  Project: Other project

• A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose Finding Study To Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates against COVID 19 in Healthy Adults

  Rupp, R.

  6/19/20 → 6/18/24

  Project: Other project

• A Phase 1/2, Placebo-Controlled, Randomized, Observer-Blind, Dose Finding Study To Describe the Safety, Tolerability, Immunogenicity, and Potential Efficacy of SARS-CoV-2 RNA Vaccine Candidates against COVID 19 in Healthy Adults

  Rupp, R.

  Pfizer, Inc.

  6/19/20 → 6/18/24

  Project: Other project

• A Phase 1/2 Study of Delayed Heterologous SARS-CoV-2 Vaccine Dosing (Boost) after Receipt of EUA Vaccines

  Rupp, R.

  7/14/21 → 11/30/22

  Project: Other project

• A Phase 1b, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine When Administered to Adults, and

  Rupp, R.

  2/12/20 → 2/11/25

  Project: Other project

• A Phase 1b, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Trial to Evaluate the Safety and Immunogenicity of mRNA-1653, a Combined Human Metapneumovirus (hMPV) and Parainfluenza Virus Type 3 (PIV3) Vaccine When Administered to Adults, and

  Rupp, R.

  2/12/20 → 2/11/25

  Project: Other project

• A Phase 2, Multicenter, Double-masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients with Presbyopia

  Merkley, K.

  9/21/16 → 9/20/18

  Project: Other project

• A Phase 2, Multicenter, Double-masked, Randomized, Vehicle-Controlled, Parallel-Group Study Evaluating the Safety, Efficacy, and Pharmacokinetics of the Fixed Combination of AGN-199201 and AGN-190584 in Patients with Presbyopia

  Merkley, K.

  9/21/16 → 9/20/18

  Project: Other project

• A Phase 2, Randomized, Double-Blind, Multicenter Study to Evaluate the Safety and Immunogenicity of Three Different Potency Levels of V181 (Dengue Quadrivalent Vaccine rDENV30 live, attenuated in Healthy Adults

  Rupp, R.

  4/1/22 → 3/31/27

  Project: Other project

• A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Corticosteroids and at least one additional asthma control

  Calhoun, W.

  2/6/19 → 2/5/22

  Project: Other project

• A Phase 2, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Tezepelumab on Airway Inflammation in Adults with Inadequately Controlled Asthma on Inhaled Corticosteroids and at least one additional asthma control

  Calhoun, W.

  2/6/19 → 2/5/22

  Project: Other project

• A PHASE 2, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

  Rupp, R.

  3/30/18 → 3/29/21

  Project: Other project

• A PHASE 2, RANDOMIZED, DOUBLE-BLIND TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

  Rupp, R.

  3/30/18 → 3/29/21

  Project: Other project

• A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH, OR SEPARATELY FROM, 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

  Rupp, R.

  7/5/18 → 7/4/21

  Project: Other project

• A PHASE 2, RANDOMIZED, OPEN-LABEL TRIAL TO EVALUATE THE SAFETY AND IMMUNOGENICITY OF A MULTIVALENT PNEUMOCOCCAL CONJUGATE VACCINE GIVEN WITH, OR SEPARATELY FROM, 13-VALENT PNEUMOCOCCAL CONJUGATE VACCINE IN HEALTHY INFANTS

  Rupp, R.

  7/5/18 → 7/4/23

  Project: Other project

• A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction with Progestin Therapy in Patients with Endometrial Carcinoma

  Richardson, G.

  10/6/17 → 10/5/19

  Project: Other project

• A Phase 2, Single Arm, Two Period Study of Sodium Cridanimod in Conjunction with Progestin Therapy in Patients with Endometrial Carcinoma

  Richardson, G.

  10/6/17 → 10/5/19

  Project: Other project

• A Phase 2a Randomized Controlled Trial of MIB-626 ² Nicotinamide Mononucleotide, NMN versus Placebo in Adults with COVID-19 Infection and Early Acute Kidney Injury

  Volpi, E.

  8/2/21 → 8/1/26

  Project: Other project

• A Phase 2b, Randomized, Double-Blind, Double-Dummy, Active-Controlled, Multicenter Study of HTX-019 as Treatment for Postoperative Nausea and Vomiting Following Failed Antiemetic Prophylaxis

  Babazade, R.

  11/16/21 → 12/2/23

  Project: Other project

• A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term Infants

  Rupp, R.

  Merck Sharp & Dohme Corporation

  1/29/21 → 1/28/26

  Project: Other project

• A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination with Phototherapy in Neonates

  Shattuck, K.

  9/26/13 → 9/25/17

  Project: Other project

• A Phase 2 Multicenter, Single Dose, Randomized, Double Blind, Placebo Controlled, Parallel Group Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination with Phototherapy in Neonates

  Shattuck, K.

  9/26/13 → 9/25/17

  Project: Other project